1 |
Tiller G, Lammerts RGM, Karijosemito JJ, Alkaff FF, Diepstra A, Pol RA, Meter-arkema AH, Seelen MA, van den Heuvel MC, Hepkema BG, Daha MR, van den Born J, Berger SP. Weak Expression of Terminal Complement in Active Antibody-Mediated Rejection of the Kidney. Front Immunol 2022;13:845301. [DOI: 10.3389/fimmu.2022.845301] [Reference Citation Analysis]
|
2 |
Jiang S, Di D, Jiao Y, Zou G, Gao H, Li W. Complement Deposition Predicts Worsening Kidney Function and Underlines the Clinical Significance of the 2010 Renal Pathology Society Classification of Diabetic Nephropathy. Front Immunol 2022;13:868127. [PMID: 35711407 DOI: 10.3389/fimmu.2022.868127] [Reference Citation Analysis]
|
3 |
Poppelaars F, Faria B, Schwaeble W, Daha MR. The Contribution of Complement to the Pathogenesis of IgA Nephropathy: Are Complement-Targeted Therapies Moving from Rare Disorders to More Common Diseases? J Clin Med 2021;10:4715. [PMID: 34682837 DOI: 10.3390/jcm10204715] [Reference Citation Analysis]
|
4 |
Boesen EI, Kakalij RM. Autoimmune-mediated renal disease and hypertension. Clin Sci (Lond) 2021;135:2165-96. [PMID: 34533582 DOI: 10.1042/CS20200955] [Reference Citation Analysis]
|